Medical Equipment

The Recombinant DNA Technology Market Is Advancing With Support From Rising Development Of Genetically Modified Crops To Drive Market Growth

May 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Recombinant DNA Technology Market Increase Between 2026 And 2030?

The market for recombinant DNA technology has shown robust growth over recent years. Forecasters predict it will expand from $913.42 billion in 2025 to reach $998.83 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be linked to factors such as the broader scope of molecular biology research, a greater occurrence of chronic diseases, advancements in biologics development, increased financial support for research from academic institutions and governments, and the initial market introduction of recombinant therapies.

The recombinant dna technology market size is projected to experience robust expansion in the coming years, with its valuation set to reach $1414.92 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast timeframe stems from several factors, such as escalating investments directed towards gene therapy development, a surging need for personalized medicine, the broadening scope of CRISPR-based applications, an intensified focus on sustainable bioproduction, and heightened cooperation between academic institutions and industrial sectors. Key developments anticipated in this period encompass the wider embrace of gene editing platforms, an increase in the creation of recombinant vaccines, a greater utilization of advanced expression systems, the enlargement of cell and gene therapy pipelines, and a stronger emphasis on scalable biomanufacturing techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8233&type=smp

Which Drivers Are Advancing The Recombinant DNA Technology Market Growth?

The expanding creation of genetically modified crops is anticipated to boost the recombinant DNA technology market in the future. Genetically modified crops are defined as plants whose genetic material has been deliberately modified through biotechnological methods. Recombinant DNA (rDNA) technology is applied in genetically modified (GM) crops through a process that includes isolating genes for desirable traits, creating recombinant DNA, inserting it into host crop cells, screening for successful integration, growing transgenic plants, assessing trait expression, conducting field tests, securing regulatory approval, and finally commercializing crops with enhanced characteristics. As an illustration, in December 2023, data from the United States Department of Agriculture, a US-based government agency, showed that Canada cultivated 11.7 million hectares of genetically engineered (GE) crops, mainly canola, soybeans, and corn. This constituted a 4% increase from 2022, primarily due to the growth in canola cultivation areas. Consequently, the rising development of genetically modified crops is propelling the expansion of the recombinant DNA technology market.

How Is Segment Classification Applied In The Recombinant DNA Technology Market?

The recombinant dna technology market covered in this report is segmented –

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell And Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

Subsegments:

1) By Recombinant Protein Drugs: Hormones, Growth Factors

2) By Vaccines: Recombinant Viral Vaccines, Recombinant Bacterial Vaccines, Subunit Vaccines

3) By Genetically Modified Crops: Herbicide-Tolerant Crops, Insect-Resistant Crops, Nutritionally Enhanced Crop

4) By Expression Systems: Bacterial Expression Systems, Yeast Expression Systems, Mammalian Expression Systems

5) By Cell And Gene Therapy: Cell-Based Therapies, Gene Replacement Therapies, CAR T-Cell Therapies

6) By Gene Editing: CRISPR Or Cas9 Technologies, TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases)

What Trends Are Influencing The Recombinant DNA Technology Market Outlook?

Leading companies within the recombinant DNA technology market are increasingly focusing on integrating advanced gene-editing methods, such as clustered regularly interspaced short palindromic repeats (CRISPR)-based recombinant DNA engineering, to improve precision, therapeutic effectiveness, and specific genome alterations. CRISPR-based recombinant DNA engineering is a molecular technique that utilizes a guide RNA and the Cas9 enzyme to pinpoint and cut specific DNA sequences, thereby enabling capabilities like precise gene correction, controlled DNA insertion, and efficient genomic modification. For example, in December 2023, Vertex Pharmaceuticals, a US-based biotechnology company, alongside CRISPR Therapeutics, a Switzerland-based gene-editing biotechnology company, received approval from the US Food and Drug Administration for Casgevy. This CRISPR-enabled recombinant DNA therapy is designed for the treatment of sickle cell disease and transfusion-dependent beta thalassemia by modifying a patient’s own stem cells to increase fetal hemoglobin production. Casgevy offers targeted DNA cleavage, high-fidelity gene modification, and ex vivo cell processing. Casgevy improves treatment outcomes by facilitating durable gene correction, reducing reliance on conventional treatments, and supporting long-term clinical benefits.

Which Key Players Are Active In The Recombinant DNA Technology Market?

Major companies operating in the recombinant dna technology market are Profacgen BioTech Corp, Amgen Inc, Novartis International AG, GenScript Biotech Corporation, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A, Merck & Co. Inc, Biogen Inc, GlaxoSmithKline PLC, New England Biolabs Inc, Bayer CropScience, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, Gilead Sciences Inc, Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc, bluebird bio Inc, Lonza Group AG, Horizon Discovery Group PLC, Sarepta Therapeutics Inc, Sangamo Therapeutics Inc

Access The Complete Recombinant DNA Technology Market Report:

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Which Region Has The Strongest Presence In The Recombinant DNA Technology Market?

North America was the largest region in the recombinant DNA technology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Recombinant DNA Technology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Browse Through More Reports Similar to the Global Recombinant DNA Technology Market 2026, By The Business Research Company

Plasmid Dna Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Dna Digital Data Storage Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-digital-data-storage-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795